Innovent Biologics seeks to attract $422M in HK IPO
Note: This section contains information in English only.
Mon, 15 Oct 2018 08:30:52 GMT
Source: Dukascopy Bank SA
China's biotech company Innovent Biologics is seeking to attract $422M in its initial public offering in Hong Kong that could potentially be the largest biotech IPO in this year's financial hub.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.